Dimension Reduction for Mapping mRNA Abundance as Quantitative Traits

Corresponding author: Alan D. Attie, University of Wisconsin, 433 Babcock Dr., Madison, WI 53706., attie{at}biochem.wisc.edu (E-mail)

Communicating editor: G. CHURCHILL

The advent of sophisticated genomic techniques for gene mapping and microarray analysis has provided opportunities to map mRNA abundance to quantitative trait loci (QTL) throughout the genome. Unfortunately, simple mapping of each individual mRNA trait on the scale of a typical microarray experiment is computationally intensive, subject to high sample variance, and therefore underpowered. However, this problem can be addressed by capitalizing on correlation among the large number of mRNA traits. We present a method to reduce the dimensionality for mapping gene expression data as quantitative traits. We used a blind method, principal components, and a sighted method, hierarchical clustering seeded by disease relevant traits, to define new traits composed of a small collection of promising mRNAs. We validated the principle of our approach by mapping the expression levels of metabolism genes in a population of F₂-ob/ob mice derived from the BTBR and C57BL/6J strains. We found that lipogenic and gluconeogenic mRNAs, which are known targets of insulin action, were closely associated with the insulin trait. Multiple interval mapping and Bayesian interval mapping of this new trait revealed significant linkages to chromosome regions that were contained in loci associated with type 2 diabetes in this same mouse sample. As a further statistical refinement, we show that principal component analysis also effectively reduced dimensions for mapping phenotypes composed of mRNA abundances.

This article has been cited by other articles:

				Z. Jia and S. Xu Mapping Quantitative Trait Loci for Expression Abundance Genetics, May 1, 2007; 176(1): 611 - 623. [Abstract] [Full Text] [PDF]

				S. M. Clee and A. D. Attie The Genetic Landscape of Type 2 Diabetes in Mice Endocr. Rev., February 1, 2007; 28(1): 48 - 83. [Abstract] [Full Text] [PDF]

				B. Munneke, K. A. Schlauch, K. L. Simonsen, W. D. Beavis, and R. W. Doerge Adding Confidence to Gene Expression Clustering Genetics, August 1, 2005; 170(4): 2003 - 2011. [Abstract] [Full Text] [PDF]

				O. Carlborg, D. J. De Koning, K. F. Manly, E. Chesler, R. W. Williams, and C. S. Haley Methodological aspects of the genetic dissection of gene expression Bioinformatics, May 15, 2005; 21(10): 2383 - 2393. [Abstract] [Full Text] [PDF]

				C. Jin, H. Lan, A. D. Attie, G. A. Churchill, D. Bulutuglo, and B. S. Yandell Selective Phenotyping for Increased Efficiency in Genetic Mapping Studies Genetics, December 1, 2004; 168(4): 2285 - 2293. [Abstract] [Full Text] [PDF]

				F. Zou, J. P. Fine, J. Hu, and D. Y. Lin An Efficient Resampling Method for Assessing Genome-Wide Statistical Significance in Mapping Quantitative Trait Loci Genetics, December 1, 2004; 168(4): 2307 - 2316. [Abstract] [Full Text] [PDF]

				A. Ghazalpour, S. Doss, X. Yang, J. Aten, E. M. Toomey, A. Van Nas, S. Wang, T. A. Drake, and A. J. Lusis Thematic review series: The Pathogenesis of Atherosclerosis. Toward a biological network for atherosclerosis J. Lipid Res., October 1, 2004; 45(10): 1793 - 1805. [Abstract] [Full Text] [PDF]

				D. J. Schaid The complex genetic epidemiology of prostate cancer Hum. Mol. Genet., April 1, 2004; 13(90001): R103 - 121. [Abstract] [Full Text] [PDF]

				H. Lan, M. E. Rabaglia, K. L. Schueler, C. Mata, B. S. Yandell, and A. D. Attie Distinguishing Covariation From Causation in Diabetes: A Lesson From the Protein Disulfide Isomerase mRNA Abundance Trait Diabetes, January 1, 2004; 53(1): 240 - 244. [Abstract] [Full Text] [PDF]

				D. Pomp, M. F. Allan, and S. R. Wesolowski Quantitative genomics: Exploring the genetic architecture of complex trait predisposition J Anim Sci, January 1, 2004; 82(13_suppl): E300 - 312. [Abstract] [Full Text] [PDF]